JXN:NYE-Jackson Financial Inc (USD)

COMMON STOCK | Insurance - Life |

Last Closing

USD 86.19

Change

-0.18 (-0.21)%

Market Cap

USD 6.32B

Volume

0.57M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-08-28 )

Largest Industry Peers for Insurance - Life

Symbol Name Price(Change) Market Cap
AFL Aflac Incorporated

+0.62 (+0.57%)

USD 60.81B
MET-PA MetLife Inc Preferred Stock Se..

+0.05 (+0.20%)

USD 47.84B
MET-PE MetLife Inc Preferred Stock Se..

+0.04 (+0.16%)

USD 43.91B
PRU Prudential Financial Inc

+0.42 (+0.36%)

USD 41.04B
PUK Prudential Public Limited Comp..

+0.11 (+0.67%)

USD 22.70B
PRI Primerica Inc

+1.39 (+0.55%)

USD 8.63B
FG F&G Annuities & Life Inc.

+1.68 (+4.18%)

USD 5.08B
ANG-PB American National Group Inc

-0.04 (-0.16%)

N/A
ANG-PA American National Group Inc.

+0.04 (+0.16%)

N/A
MET-PF MetLife Inc Preferred Stock Se..

+0.16 (+0.72%)

N/A

ETFs Containing JXN

MVPA Advisor Managed Portfolio.. 4.27 % 0.00 %

+0.53 (+2.42%)

USD 0.05B
FSCC Federated Hermes ETF Trus.. 2.34 % 0.00 %

+0.60 (+2.42%)

N/A
CPAI Northern Lights Fund Trus.. 2.31 % 0.00 %

+0.55 (+2.42%)

USD 0.02B
EBIT Harbor ETF Trust 1.56 % 0.00 %

+0.88 (+2.42%)

N/A
ROSC Hartford Multifactor Smal.. 1.45 % 0.00 %

+1.07 (+2.42%)

USD 0.03B
XSVM Invesco S&P SmallCap Valu.. 1.36 % 0.39 %

+1.51 (+2.42%)

USD 0.79B
MYLD 1.22 % 0.00 %

N/A

N/A
WCEO Hypatia Women Ceo ETF 1.00 % 0.00 %

+0.62 (+2.42%)

USD 3.52M
IJS iShares S&P Small-Cap 600.. 0.93 % 0.25 %

+2.81 (+2.42%)

USD 6.87B
AVUV Avantis® U.S. Small Cap .. 0.85 % 0.00 %

+2.33 (+2.42%)

USD 12.53B
USSC:LSE SPDR® MSCI USA Small Cap.. 0.67 % 0.00 %

+1.53 (+2.42%)

USD 0.50B
ZPRV:F SSgA SPDR ETFs Europe II .. 0.67 % 0.00 %

+1.21 (+2.42%)

USD 0.50B
DFSV Dimensional ETF Trust 0.65 % 0.00 %

+0.75 (+2.42%)

USD 3.48B
2B77:XETRA iShares Ageing Population.. 0.64 % 0.00 %

+0.10 (+2.42%)

USD 0.50B
AGED:SW iShares Ageing Population.. 0.59 % 0.00 %

+0.08 (+2.42%)

N/A
QVMS Invesco Exchange-Traded F.. 0.54 % 0.00 %

+0.67 (+2.42%)

USD 0.19B
VRTVX Vanguard Scottsdale Funds.. 0.49 % 0.00 %

+7.19 (+2.42%)

USD 0.91B
DFAT Dimensional U.S. Targeted.. 0.49 % 0.00 %

+1.34 (+2.42%)

USD 9.95B
EZM WisdomTree U.S. MidCap Ea.. 0.00 % 0.38 %

+1.42 (+2.42%)

N/A
FNK First Trust Mid Cap Value.. 0.00 % 0.70 %

+1.24 (+2.42%)

USD 0.22B
IWN iShares Russell 2000 Valu.. 0.00 % 0.00 %

+4.11 (+2.42%)

N/A
PSCF Invesco S&P SmallCap Fina.. 0.00 % 0.29 %

+1.32 (+2.42%)

USD 0.02B
RDVY First Trust Rising Divide.. 0.00 % 0.50 %

+0.72 (+2.42%)

USD 11.66B
PSC Principal U.S. Small-Cap .. 0.00 % 0.38 %

+1.05 (+2.42%)

USD 0.62B
AGED:LSE iShares Ageing Population.. 0.00 % 0.00 %

+0.11 (+2.42%)

N/A
AGES:LSE iShares IV Public Limited.. 0.00 % 0.00 %

+5.75 (+2.42%)

N/A
SLYV SPDR® S&P 600 Small Cap .. 0.00 % 0.15 %

+2.24 (+2.42%)

N/A
VIOV Vanguard S&P Small-Cap 60.. 0.00 % 0.20 %

+2.30 (+2.42%)

N/A
VTWV Vanguard Russell 2000 Val.. 0.00 % 0.20 %

+3.63 (+2.42%)

USD 0.79B
GSSC Goldman Sachs ActiveBeta.. 0.00 % 0.20 %

+1.70 (+2.42%)

USD 0.49B
ZPRV:XETRA SPDR® MSCI USA Small Cap.. 0.00 % 0.00 %

+1.11 (+2.42%)

USD 0.50B
2B77:F iShares Ageing Population.. 0.00 % 0.00 %

+0.06 (+2.42%)

N/A

Market Performance

  Market Performance vs. Industry/Classification (Insurance - Life) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 68.34% 100% F 98% N/A
Dividend Return 2.73% 63% D 58% F
Total Return 71.07% 100% F 98% N/A
Trailing 12 Months  
Capital Gain 126.82% 100% F 99% N/A
Dividend Return 5.32% 75% C 70% C-
Total Return 132.13% 100% F 99% N/A
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 24.80% 89% A- 86% B+
Dividend Return 28.86% 89% A- 88% B+
Total Return 4.06% 63% D 72% C
Risk Return Profile  
Volatility (Standard Deviation) 49.26% 17% F 18% F
Risk Adjusted Return 58.58% 61% D- 77% C+
Market Capitalization 6.32B 25% F 80% B-

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior capital utilization

The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.

Underpriced on cashflow basis

The stock is trading low compared to its peers on a price to cash flow basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

Underpriced compared to book value

The stock is trading low compared to its peers on a price to book value basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

Underpriced compared to earnings

The stock is trading low compared to its peers on a price to earning basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.

Negative free cash flow

The company had negative total free cash flow in the most recent four quarters.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector